case_images: PMC3914197_01
case_images: Serum and urine sodium before and after DDAVP administration.
case_images: CRIM.NEPHROLOGY2012-640365.001.jpg
case_images: PMC3914197_01_CRIM.NEPHROLOGY2012-640365.001.jpg
case_images: fig1
case_images: Marked improvement was seen in the patient's hypernatremia, in which her serum sodium concentrations decreased from 158 mEq/L to143 mEq/L within 30 hours from the initial DDAVP dose (Figure 1), and normalization of her serum osmolality (Figure 2).
case_images: Serum and urine osmolality before and after DDAVP administration.
case_images: CRIM.NEPHROLOGY2012-640365.002.jpg
case_images: PMC3914197_01_CRIM.NEPHROLOGY2012-640365.002.jpg
case_images: fig2
case_images: Marked improvement was seen in the patient's hypernatremia, in which her serum sodium concentrations decreased from 158 mEq/L to143 mEq/L within 30 hours from the initial DDAVP dose (Figure 1), and normalization of her serum osmolality (Figure 2).